An open study to compare the efficacy of immunoglobulin administered subcutaneously (SCIG) with current best practice in patients with Complex Regional Pain Syndrome (CRPS).

Trial Profile

An open study to compare the efficacy of immunoglobulin administered subcutaneously (SCIG) with current best practice in patients with Complex Regional Pain Syndrome (CRPS).

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Immune globulin (Primary)
  • Indications Complex regional pain syndromes
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Oct 2012 Status changed from recruiting to active, no longer recruiting as reported by UKCRN.
    • 15 Mar 2012 Actual initiation date 5 Nov 2009 added as reported by EudraCT.
    • 27 Jul 2011 Planned end date changed from 28 Oct 2011 to 31 Dec 2013 as reported by United Kingdom Clinical Research Network record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top